Last reviewed · How we verify
The Acceptability and Feasibility of an ED-based, Peer-delivered, Suicide Safety Planning Intervention
NA trial testing Peer Supporter Safety Planning in Suicidal Ideation in 37 participants. Completed in 1 January 2021.
| Lead sponsor | University of Arkansas |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 37 |
| Start date | 6 November 2019 |
| Primary completion | 1 September 2020 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across United States |
University of Arkansas
Adults 18 to 89, any sex, with Suicidal Ideation or Suicide, Attempted. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Evaluate the number of suicidal ideology (SI) patients approached in the ED who agree to receive a safety plan.
| Group | Value | 95% CI |
|---|---|---|
| Clinical Personnel Safety Planning | 15 | |
| Peer Supporter Safety Planning | 16 |
Evaluate the proportion of patients approached who meet all inclusion/exclusion criteria.
| Group | Value | 95% CI |
|---|---|---|
| Clinical Personnel Safety Planning | 17 | |
| Peer Supporter Safety Planning | 20 |
Evaluate the quality of the completed safety plans. This will be done by retrospective review after the patient has left the ED. Safety plans will be graded individually, then resolved by consensus, for quality (0=blank, 1=boilerplate, 2=some evidence of personalization, 3=highly personalized; range=0-24) by the investigators using materials developed by Brown and Stanley for this purpose. Using a "safety checklist," responses for each of the 6 safety plan steps will be classified according to the personalization of the information in each step.
| Group | Value | 95% CI |
|---|---|---|
| Clinical Personnel Safety Planning | 8 | 7 – 9 |
| Peer Supporter Safety Planning | 12.5 | 10 – 16.5 |
Evaluate patient satisfaction with safety planning. This will be assessed by having the patient rate their experience with the safety planning process on a 7-point Likert scale (1 - strongly disagree; 2 - disagree; 3 - moderately disagree; 4 - neutral; 5 - moderately agree; 6 - agree; 7 - strongly agree). A Likert scale measures how much someone disagrees or agrees with a particular statement.
| Group | Value | 95% CI |
|---|---|---|
| Clinical Personnel Safety Planning | 4 | 4 – 4 |
| Peer Supporter Safety Planning | 4.5 | 4 – 6 |
Safety planning is a brief, ED-feasible intervention which has been demonstrated to save lives, and has been universally recommended by every recent expert consensus panel on suicide prevention strategies. In one popular version of the safety plan developed by Stanley et al, the patient is encouraged to write out the following items: identifying personal signs of a crisis; helpful internal coping strategies; social contacts or settings which may distract from a crisis; using family members or friends for help when in crisis; mental health professionals who can be contacted when in crisis; and restricting access to lethal means. In most emergency departments, safety-planning is done by clinical personnel such as psychologists or social workers, but these providers are often too busy to perform safety-planning well or have multiple other patient care responsibilities. This study aims to find out if ED patients prefer to complete a safety plan with a peer supporter or clinical personnel. People who are visiting the emergency department for thoughts of self-harm will be asked to participate.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04068142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing